 | Here's a few ideas for next week. These are the companies I'll be investing in as funds become available in my accounts. They're each showing a nice estimated 1yr ROI, increasing earnings, and pay at least a minimal dividend. I believe that each of these has a greater potential return than analysts currently expect. As with all investments, I start with small positions and then add to that position over time through dividend reinvestment, the sale of stock options and direct purchases on the open market. |
QUALCOMM Inc. develops, designs, manufactures, and markets digital communications products and services in China, South Korea, Taiwan, the United States, and internationally. The company operates through three segments: Qualcomm CDMA Technologies (QCT); Qualcomm Technology Licensing (QTL); and Qualcomm Strategic Initiatives (QSI). The QCT segment develops and supplies integrated circuits and system software based on code division multiple access (CDMA), orthogonal frequency division multiple access (OFDMA), and other technologies for use in voice and data communications, networking, application processing, multimedia, and global positioning system products. The QTL segment grants licenses or provides rights to use portions of its intellectual property portfolio, which include various patent rights useful in the manufacture and sale of certain wireless products comprising products implementing CDMA2000, WCDMA, CDMA TDD, and/or LTE standards, as well as their derivatives. The QSI segment invests in early-stage companies in various industries, including digital media, e-commerce, healthcare, and wearable devices for supporting the design and introduction of new products and services for voice and data communications. The company also develops and offers products for implementation of small cells; mobile health products and services; software products, and content and push-to-talk enablement services to wireless operators; and development, and other services and related products to the United States government agencies and their contractors. In addition, it licenses chipset technology and products for data centers. QUALCOMM Incorporated was founded in 1985 and is headquartered in San Diego, California.
(Summary) (Company) (Chart)
(Summary) (Company) (Chart)
| 19 February 2017 Price $56.46 1yr Target $65.54 Analysts 24 Dividend $2.12 Payout Ratio 64.63% 1yr Cap Gain 16.08% Yield 3.75% 1yr Tot Return 19.83% P/E 17.21 PEG 1.64 Beta 1.31 | EPS (ttm) $3.28 EPS next yr $4.80 Forward P/E 11.76 EPS next 5yr 10.50% 1yr Price Support $50.40 Market Cap $83.45 Bil Revenues $23.78 Bil Earnings $4.89 Bil Profit Margin 20.56% Quick Ratio 1.70 Current Ratio 2.00 Debt/Equity 0.37 | 1yr RevGR -6.84% 3yr RevGR -1.78% 5yr RevGR 9.49% 1yr EarnGR 18.32% 3yr EarnGR -0.86% 5yr EarnGR 8.61% 1yr DivGR 12.22% 3yr DivGR 16.90% 5yr DivGR 20.05% ROA 9.50% ROE 15.90% |
 Qualcomm Monthly Chart |  Qualcomm Dividend History |
Kennedy-Wilson Holdings, Inc. operates as a real estate investment company. The company owns, operates, and invests in real estate both on its own and through its investment management platform. It focuses on multifamily and commercial properties located in the Western United States, the United Kingdom, Ireland, Spain, Italy, and Japan. The company owns interest in approximately 39 million square feet of property, including 24,371 multifamily rental units. It also provides real estate services primarily to financial services clients. Kennedy-Wilson Holdings, Inc. was founded in 1977 and is headquartered in Beverly Hills, California.
(Summary) (Company) (Chart)
(Summary) (Company) (Chart)
| 26 February 2017 Price $21.90 1yr Target $30.00 Analysts 6 Dividend $0.68 Payout Ratio 518.18% 1yr Cap Gain 36.98% Yield 3.10% 1yr Tot Return 40.08% P/E 195.54 PEG 7.82 Beta 1.29 | EPS (ttm) $0.11 EPS next yr $-0.51 Forward P/E --- EPS next 5yr 25.00% 1yr Price Support --- Market Cap $2.37 Bil Revenues $689.20 Mil Earnings $15.10 Mil Profit Margin 2.19% Quick Ratio --- Current Ratio --- Debt/Equity 4.67 | 1yr RevGR 51.45% 3yr RevGR 106.67% 5yr RevGR 64.22% 1yr EarnGR 371.42% 3yr EarnGR --- 5yr EarnGR --- 1yr DivGR 33.33% 3yr DivGR 33.49% 5yr DivGR --- ROA 0.00% ROE 0.20% |
 Kennedy Wilson Monthly Chart |  Kennedy Wilson Dividend History |
Gildan Activewear Inc. manufactures and sells apparel products in the United States, Canada, Europe, the Asia-Pacific, and Latin America. It operates in two segments, Printwear and Branded Apparel. The Printwear segment designs, manufactures, sources, and distributes undecorated activewear products comprising T-shirts, fleece, and sport shirts under Gildan, Gildan Performance, Anvil, Comfort Colors, and New Balance brands. Its activewear products are used in various activities by individuals, including work and school uniforms and athletic team wear, and other purposes to convey individual, group, and team identity. The Branded Apparel segment designs, manufactures, sources, markets, and distributes branded family apparel, which includes athletic, casual, and dress socks, as well as underwear, activewear, sheer hosiery, legwear, and shapewear products. This segment markets its products under various brands, including Gildan, Gildan Platinum, Gold Toe, Smart Basics, G, PowerSox, Silver Toe, All Pro, Secret, Silks, Therapy Plus, Kushyfoot, and Secret Silky brands, as well as under licensing agreements under the Under Armour and Mossy Oak brands. Gildan Activewear Inc. serves wholesale distributors, mass-market retailers, department stores, national and regional chains, sports specialty stores, and price clubs. The company was formerly known as Textiles Gildan Inc. and changed its name to Gildan Activewear Inc. in March 1995. Gildan Activewear Inc. was incorporated in 1984 and is headquartered in Montreal, Canada.
(Summary) (Company) (Chart)
(Summary) (Company) (Chart)
| 26 February 2017 Price $25.58 1yr Target $30.41 Analysts 14 Dividend $0.31 Payout Ratio 21.67% 1yr Cap Gain 18.88% Yield 1.21% 1yr Tot Return 20.09% P/E 17.86 PEG 1.25 Beta 1.03 | EPS (ttm) $1.43 EPS next yr $1.87 Forward P/E 13.70 EPS next 5yr 14.25% 1yr Price Support $26.64 Market Cap $5.96 Bil Revenues $2.54 Bil Earnings $340.00 Mil Profit Margin 13.38% Quick Ratio 1.60 Current Ratio 5.70 Debt/Equity 0.28 | 1yr RevGR % 3yr RevGR % 5yr RevGR % 1yr EarnGR % 3yr EarnGR % 5yr EarnGR % 1yr DivGR % 3yr DivGR % 5yr DivGR % ROA 11.40% ROE 16.60% |
 Gildan Monthly Chart |  Gildan Dividend History |
LeMaitre Vascular, Inc. develops, manufactures, and markets medical devices and implants for the treatment of peripheral vascular disease worldwide. The company provides angioscope, a fiber optic catheter used for viewing the lumen of a blood vessel; carotid shunts to temporarily divert or shut blood to the brain during the removal of plaque from the carotid artery in a carotid endarterectomy surgery; and powered phlebectomy devices that enable less invasive removal of varicose veins. It also offers embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that temporarily occlude blood flow; and perfusion catheters that temporarily perfuse blood and other liquids into the vasculature. In addition, the company provides radiopaque tape, a medical-grade tape applied to the skin and provides interventionists to cross-reference between the inside and the outside of a patient’s body, and allows them to locate tributaries or lesions beneath the skin; and remote endarterectomy devices to remove severe atherosclerotic blockages from the arteries of the leg. Further, it offers valvulotomes for use as a bypass vessel to carry blood past diseased arteries to the lower leg or the foot; vascular grafts to bypass or replace diseased arteries; vascular patches used in conjunction with carotid endarterectomy, remote endarterectomy, and other vascular reconstructions; vessel closure systems that allows surgeons to attach vessels to one another by deploying titanium clips in place of suturing; and laparoscopic cholecystectomy devices to inject dye into the cystic duct during laparoscopic cholecystectomy. LeMaitre Vascular, Inc. markets its products through direct and indirect sales force, as well as distributors. The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001. LeMaitre Vascular, Inc. was founded in 1983 and is headquartered in Burlington, Massachusetts.
(Summary) (Company) (Chart)
(Summary) (Company) (Chart)
| 26 February 2017 Price $22.17 1yr Target $26.00 Analysts 5 Dividend $0.22 Payout Ratio 40.00% 1yr Cap Gain 17.27% Yield 0.99% 1yr Tot Return 18.26% P/E 40.16 PEG 2.68 Beta 0.64 | EPS (ttm) $0.55 EPS next yr $0.79 Forward P/E 28.06 EPS next 5yr 15.00% 1yr Price Support $11.85 Market Cap $407.04 Mil Revenues $89.20 Mil Earnings $10.60 Mil Profit Margin 11.88% Quick Ratio 3.80 Current Ratio 5.60 Debt/Equity 0.00 | 1yr RevGR 10.20% 3yr RevGR 11.24% 5yr RevGR 6.92% 1yr EarnGR 82.60% 3yr EarnGR 37.50% 5yr EarnGR 2.56% 1yr DivGR 14.28% 3yr DivGR 16.77% 5yr DivGR --- ROA 10.80% ROE 12.50% |
 LeMaitre Monthly Chart |  LeMaitre Dividend History |
RSS Feed
